Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-09

Clinical Trial Update: Exploratory Study on Dosage of Qizhi Weitong Granules in the Treatment of Irritable Bowel Syndrome (IBS) [Phase 2]

View source ↗

Summary

Phase 2 exploratory study evaluating dosage of Qizhi Weitong Granules for Irritable Bowel Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Qizhi Weitong Granules

Snippet

Sponsor: China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: UNKNOWN